Basic HTML Version
129
SCIENTIFIC REPORT 2012
Title:
Prospective epidemiological study on contrast nephropathy in patients
critics.
District Attorney:
SEMICYUC
Principal Investigator:
Anna Navas Pérez.
Title:
Record of renal replacement therapy in patients with acute renal failure.
District Attorney:
SC Nephrology and SCM Intensive.
Principal Investigator:
Anna Navas Pérez.
Title:
Double-blind clinical trial of keratolytic hair gel GV-264 in leather psoriasis
hairy.
District Attorney:
Laboratorios Viñas SA
Principal Investigator:
Miquel Ribera Pibernat.
Title:
Follow-up Study Up to Adult Size of Patients Included in the Phase Study
III with Omnitrope® Treatment in Spanish Children with Hormone Deficiency of
Growth.
District Attorney:
Sandoz Farmacéutica SA
Principal Investigator:
Raquel Corripio Collado.
Title:
Epidemiological study on the current status of patients with
Gaucher type I in Spain, evaluated by Therapeutic Goals MAP (Monitor, Action and
Progress) Tool ©. Studio MAPPING EG.
District Attorney:
SHIRE Pharmaceuticals Ibérica (HGT).
Principal Investigator:
Imma Roig Martínez.
Title:
Use of Omalizumab in actual clinical practice in Spain after 5 years of experience.
EXpert Study 5.
District Attorney:
Novartis Farmacéutica SA
.
Principal Investigator:
Montserrat Bosque García.
Title:
Intervention study: conciliation of peripheral medication in traumatological surgery.
District Attorney:
Own.
Principal Investigator:
Marta Cabré Serres.